Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mendell HeliumLSE:MDH +4.85% EBIT per Share is £-0.00 as of Dec. 2025. Among 812 Drug Manufacturers companies, Mendell Helium ranks worse than 123152.59% on this metric.
Mendell Helium's EBIT per Share for the
six
months ended in Dec. 2025 was £0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £-0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Mendell Helium's EBIT per Share or its related term are showing as below:
LSE:MDH's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.5 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Mendell Helium's EBIT for the
six
months ended in Dec. 2025 was £-0.16 Mil.
Mendell Helium (LSE:MDH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Mendell Helium EBIT per Share Related Terms
Mendell Helium EBIT per Share Historical Data
* Premium members only.
The historical data trend for Mendell Helium's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mendell Helium (LSE:MDH) has a EBIT per Share of £-0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Mendell Helium and its competitors. According to the industry distribution chart, Mendell Helium ranks #999999 out of 812 companies in the Drug Manufacturers industry.
Is Mendell Helium's EBIT per Share too high?
Mendell Helium's current EBIT per Share is £-0.00. Based on the distribution chart, Mendell Helium ranks #999999 out of 812 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Mendell Helium's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mendell Helium ranks #999999 out of 812 companies for EBIT per Share. This places Mendell Helium in the lower half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Mendell Helium and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mendell Helium's current EBIT per Share is £-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mendell Helium stock overvalued right now?
Mendell Helium (LSE:MDH) has a current EBIT per Share of £-0.00. The current EBIT per Share is £-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Mendell Helium (LSE:MDH), the current EBIT per Share is £-0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mendell Helium PLC is a helium production and exploration company. The company operates in Kansas. The project portfolio of the company includes Fort Dodge, Hugoton, and Bitcoin Treasury.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MDH has been successfully added to your 
